Skip to content

ESCP Safe Anastomosis proGramme in coLorectal surgEry

ESCP Safe Anastomosis proGramme in coLorectal surgEry

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04270721
Acronym
EAGLE
Enrollment
4400
Registered
2020-02-17
Start date
2020-02-03
Completion date
2022-07-01
Last updated
2021-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomosis; Complications, Anastomotic Leak

Keywords

anastomotic leak, right colectomy, cluster randomised study, leak prediction

Brief summary

EAGLE is an international service improvement study to investigate the value of an educational tool delivered to surgeons and their teams to reduce the risk of anastomotic leak (leak of a join in the bowel) after right hemicolectomy or ileocaecal resection. This complication causes significant risk to life and therefore risks of leak should be minimised. The educational team of the European Society of Coloproctology has developed an online training package to deliver to 350 hospitals in 30 countries.

Detailed description

EAGLE is an international quality improvement programme to share best practice and harmonise ileo-colic anastomosis procedures through an education programme for surgeons and theatre teams. The programme has 3 main strategies: (i) enhanced pre-operative risk stratification (making sure it is safe to join the bowel together for each patient); (ii) harmonisation of surgical technique (making the join as good as it can be and checking it carefully after it is created), and (iii) implementation of an intra-operative anastomosis 'checklist' (focusing the attention of the whole theatre team at this critical stage of the operation). The investigators will use a novel scientific approach to assess the patient benefit that enables not only the quality improvement itself to be delivered to all participating hospitals but also enables collection and analysis of data to measure the effect of these measures. The best way of doing this is to embed the proposed quality improvement into a staggered implementation programme, allowing the effect to be assessed between the centres. The specific methodology proposed introduces the intervention in a step-wise fashion to all hospitals. By the end, all sites will have implemented the programme. Overall, the investigators hope to reduce the leak rate by 30% from 8.1% to 5.6% in about 4,500 patients.

Interventions

BEHAVIORALThe EAGLE Safe Anastomosis Quality Improvement Intervention

The intervention is the same in each arm; the EAGLE Safe Anastomosis Quality Improvement Intervention is an educational programme for behavioural change composed of three parts: 1. Introduction of a routine patient risk stratification for anastomotic leak 2. Implementation of the ESCP Safe Anastomosis Checklist 3. Adoption of a harmonised technique for stapled and handsewn anastomosis based on best evidence.

Sponsors

Ethicon, Inc.
CollaboratorINDUSTRY
European Society of Coloproctology
CollaboratorUNKNOWN
University of Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The patient will be blinded to their hospital's randomised sequence allocation. Analysis will be performed blind to allocation sequence (and therefore before and after status) and after data have been cleaned and locked.

Intervention model description

EAGLE is an international, multicentre, cluster-sequence randomised controlled study. The intervention will be delivered at hospital-level so randomisation will be by hospital, with outcomes assessed at the individual patient level. Cluster randomisation will follow a dog-leg phased study design with 3 randomisation sequences. In the first phase, approximately 48 hospitals (clusters) are randomised between the three sequences, all three are eventually exposed to the intervention. Sequence 1 immediately receives the training intervention and data are only collected after the intervention. In sequence 2, data are collected before and after the intervention. The final sequence collects data only before the intervention. The second dogleg phase commences after the first when more clusters are ready to participate (indicatively after one month, but can be delayed as practicable). Indicatively, 7 dogleg phases with 48 hospitals each, will achieve the sample size required (333 clusters).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adult patients (age 18 years and above) undergoing right colectomy with or without primary anastomosis. Right colectomy is defined as ileocaecal resection or right hemicolectomy (any colonic transection with the distal resection margin proximal to the splenic flexure). * All patients undergoing right colectomy are eligible, including those who do not have an anastomosis and are defunctioned by a proximal stoma. * Procedures for any pathology, via any operative approach (open, laparoscopic, robotic or converted) are eligible. * Elective (surgery on a planned admission), expedited, and emergency (surgery on an unplanned admission) procedures are eligible.

Exclusion criteria

* Patients undergoing more than one gastrointestinal anastomosis during the same operation. * In Crohn's disease, additional upstream stricturoplasty or resection/anastomosis to treat disease or strictures at the same operation. * Simultaneous right colectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) and/or cytoreductive surgery. * Each individual patient should only be included in EAGLE once. Following the index procedure that is included in EAGLE, patients undergoing additional procedures within the study window should not be included for a second time.

Design outcomes

Primary

MeasureTime frameDescription
Number of patients diagnosed clinically or radiologically with anastomotic leak within 30 days of surgeryup to 30 days from operationAnastomotic leak is defined as anastomotic leak identified radiologically or clinically, or intra-peritoneal (abdominal or pelvic) fluid collection identified radiologically, as per the Centre for Disease Control Criteria for Organ Space infection. This will be described as a rate divided by the total number of patients who had a primary anastomosis (rather than total number of patients undergoing right hemicolectomy or ileocaecal resection).

Secondary

MeasureTime frameDescription
The rate of re-operation for anastomotic leakup to 30 daysThe number of patients re-operated, of those diagnosed with anastomotic leak following right hemicolectomy or ileocaecal resection
The rate of adverse outcomes following right hemicolectomy or ileocaecal resectionup to 30 daysFor all patients included in the study (i.e. who underwent right hemicolectomy or ileocaecal resection whether or not with primary anastomosis); 1. Number of patients undergoing re-operation for any cause within 30 days 2. Number of patients with unplanned admission to critical care within 30 days 3. Number of patients re-admitted to hospital within 30 days 4. Mortality rate within 30 days
The rate of stoma formationAt index operationFor all patients included in the study (i.e. who underwent right hemicolectomy or ileocaecal resection whether or not with primary anastomosis); 1. Rate of formation of ileostomy without primary anastomosis 2. Rate of defunctioning ileostomy with primary anastomosis
Length of hospital stay following right hemicolectomy or ileocaecal resectionup to 30 daysMeasured in post-operative days

Other

MeasureTime frameDescription
Feasibility of recruitment of clusters (hospitals) in this study designThrough to study completion, expected 1 yearMeasured by the number of participating hospitals and countries
Time to site set-up in this study designThrough to study completion, expected 1 yearTime taken for study set-up at sites from registration to randomisation
Uptake of online educational modulesThrough to study completion, expected 1 yearThe proportion of eligible surgeons to undertake the educational modules in participating units.
Understanding uptake and effectiveness of online educational modulesSurgeons will have 30 days to complete the educational evaluation to collect CPD (continuing professional development) certificate. Interviews will take place 3-6 months after study completion at individual units.Semi-structured interviews will be undertaken at purposefully sampled units to assess longevity of the intervention
Adherence to implementation of the Safe Anastomosis Programmeday of index operationThe proportion of eligible patients whose team completed the pre-operative risk stratification and Safe Anastomosis Checklist

Countries

Russia

Contacts

Primary ContactJames Keatley
J.Keatley@bham.ac.uk+44 (0)121 371 8026
Backup ContactBrett Dawson
B.Dawson@bham.ac.uk+44 (0) 121 371 8140

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026